Results 141 to 150 of about 1,299,020 (330)

Assessing the Impact of Blood Pressure on Cardiac Function Using Interpretable Biomarkers and Variational Autoencoders [PDF]

, 2019
Maintaining good cardiac function for as long as possible is a major concern for healthcare systems worldwide and there is much interest in learning more about the impact of different risk factors on cardiac health. The aim of this study is to analyze the impact of systolic blood pressure (SBP) on cardiac function while preserving the interpretability ...
arxiv   +1 more source

Light‐chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome

European Journal of Heart Failure, 2020
Concomitant cardiac amyloidosis (CA) in severe aortic stenosis (AS) is difficult to recognize, since both conditions are associated with concentric left ventricular thickening.
C. Nitsche, S. Aschauer, A. Kammerlander, M. Schneider, T. Poschner, F. Duca, Christina Binder, M. Koschutnik, Julian Stiftinger, G. Goliasch, J. Siller-Matula, M. Winter, Anahit Anvari-Pirsch, M. Andreas, A. Geppert, D. Beitzke, C. Loewe, M. Hacker, H. Agis, R. Kain, I. Lang, D. Bonderman, C. Hengstenberg, J. Mascherbauer   +23 more
semanticscholar   +1 more source

Dilated cardiomyopathy evaluation with Imagenomics: combining multimodal cardiovascular imaging and genetics

ESC Heart Failure, EarlyView.
Systematic approach to dilated cardiomyopathy diagnosis. Dilated cardiomyopathy is a clinical diagnosis characterized by the presence of left ventricular dilatation and systolic disfunction unexplained by abnormal loading conditions or coronary artery disease.
Kristian Galanti, Ghaith Sharaf Dabbagh, Fabrizio Ricci, Sabina Gallina, Roberta Giansante, Ron Jacob, Edmond Obeng‐Gyimah, Leslie T. Cooper Jr, Sanjay K. Prasad, David H. Birnie, Andrew P. Landstrom, Selma F. Mohammed, Saidi Mohiddin, Mohammed Y. Khanji, Anwar A. Chahal   +14 more
wiley   +1 more source

A thousand words about the imaging in cardiac amyloidosis

Journal of Medical Science, 2019
Cardiac amyloidosis is an infiltrative disease which usually occurs under the form of restrictive cardiomyopathy. Advances in the treatment have changed the unfavorable outcomes of this disease. Thus, early diagnosis is essential.
Rafał Dankowski, Marek Leszniewski, Małgorzata Pyda, Andrzej Szyszka   +3 more
doaj   +1 more source

A Computer Vision Pipeline for Automated Determination of Cardiac Structure and Function and Detection of Disease by Two-Dimensional Echocardiography [PDF]

arXiv, 2017
Automated cardiac image interpretation has the potential to transform clinical practice in multiple ways including enabling low-cost serial assessment of cardiac function in the primary care and rural setting. We hypothesized that advances in computer vision could enable building a fully automated, scalable analysis pipeline for echocardiogram (echo ...
arxiv  

Multi-Imaging Characterization of Cardiac Phenotype in Different Types of Amyloidosis [PDF]

, 2022
BACKGROUND: Bone scintigraphy is extremely valuable when assessing patients with suspected cardiac amyloidosis (CA), but the clinical significance and associated phenotype of different degrees of cardiac uptake across different types is yet to be defined.
Brown, James, Chacko, Liza, Fontana, Marianna, Gillmore, Julian D, Hawkins, Philip N, Ioannou, Adam, Kellman, Peter, Knight, Daniel, Kotecha, Tushar, Lachmann, Helen, Manisty, Charlotte, Martinez-Naharro, Ana, Moon, James, Patel, Rishi K, Porcari, Aldostefano, Razvi, Yousuf, Venneri, Lucia, Wechelakar, Ashutosh, Whelan, Carol, Wisniowski, Brendan   +19 more
core  

Delays in diagnosis and treatment of ATTR cardiac amyloidosis: A real‐world data analysis

ESC Heart Failure, EarlyView.
Abstract Aims and Background Cardiac amyloidosis leads to functional cardiac impairment and heart failure. Transthyretin amyloid cardiomyopathy (ATTR‐CM) is the most common form. After initial suspicion, diagnosis involves imaging techniques, biopsy and genetic tests, prompting transthyretin stabilizer therapy to slow disease progression.
Julia Vogel, Sophia Jura, Stephan Settelmeier, Florian Buehning, Tobias Lerchner, Alexander Carpinteiro, Tienush Rassaf, Lars Michel   +7 more
wiley   +1 more source

Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles [PDF]

, 2019
OBJECTIVES: This cross-sectional study aimed to describe the functional and structural cardiac abnormalities that occur across a spectrum of cardiac amyloidosis burden and to identify the strongest cardiac functional and structural prognostic predictors ...
Abdel-Gadir, A, Barcella, W, Bulluck, H, Fontana, M, Francis, R, Gillmore, JD, Hawkins, PN, Knight, DS, Kotecha, T, Lachmann, HJ, Martinez-Naharro, A, Moon, JC, Muthurangu, V, Quarta, CC, Rezk, T, Steeden, JA, Treibel, TA, Wechalekar, AD, Whelan, CJ, Zumbo, G   +19 more
core  

Sudden death in lambda light chain AL cardiac amyloidosis: a review of literature and update for clinicians and pathologists [PDF]

, 2020
Light chain (AL) amyloidosis is the most common type of systemic amyloidosis, affecting around 10 people per million per year. In Europe, approximately 5000 new diagnosis per year are reported.
Baldari, Benedetta, D'Errico, Stefano, Fineschi, Vittorio, Frati, Paola, Maiese, Aniello, Mazzanti, Andrea   +5 more
core  

2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis: A Report of the American College of Cardiology Solution Set Oversight Committee.

Journal of the American College of Cardiology, 2023
M. Kittleson, F. Ruberg, A. Ambardekar, T. Brannagan, Richard K. Cheng, J. Clarke, L. Dember, Janell Grazzini Frantz, R. E. Hershberger, M. Maurer, J. Nativi-Nicolau, V. Sanchorawala, F. Sheikh   +12 more
semanticscholar   +1 more source